We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$6.39B
AUM Growth
+$1.46B
Cap. Flow
+$813M
Cap. Flow %
12.72%
Top 10 Hldgs %
30%
Holding
130
New
34
Increased
32
Reduced
37
Closed
15

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$114M
2
CNC icon
Centene
CNC
+$75.1M
3
ESPR
Esperion Therapeutics
ESPR
+$67.2M
4
SPOT icon
Spotify
SPOT
+$55.4M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$51.4M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$198M
2
MSFT icon
Microsoft
MSFT
+$102M
3
BAX icon
Baxter International
BAX
+$84.8M
4
MOH icon
Molina Healthcare
MOH
+$65.2M
5
UNH icon
UnitedHealth
UNH
+$50.1M

Sector Composition

Rank Sector Weight
1 Healthcare 48.69%
2 Technology 9.35%
3 Communication Services 7.21%
4 Consumer Discretionary 2.57%
5 Financials 2.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNNA
76
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$23.6M 0.37%
1,551,293
+117
+0% +$1.99K
MNK
77
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$23.5M 0.37%
+1,259,100
New +$20M
ALNA
78
DELISTED
Allena Pharmaceuticals
ALNA
$22.7M 0.36%
1,739,805
+275,911
+19% +$3.98M
LCI
79
CALL
DELISTED
Lannett Company, Inc.
LCI
$21.7M 0.34%
+399,500
New +$25.2M
Z icon
80
Zillow
Z
$7.68B
$21.7M 0.34%
+366,797
New +$20.3M
AAPL icon
81
Apple
AAPL
$5.03T
$21.3M 0.33%
+460,104
New +$20.9M
ARAY icon
82
Accuray
ARAY
$28.8M
$20.7M 0.32%
5,050,570
-1,373,500
-21% -$6.36M
CME icon
83
CME Group
CME
$94.4B
$20.5M 0.32%
124,955
-225,119
-64% -$36.8M
KURA icon
84
Kura Oncology
KURA
$811M
$19.8M 0.31%
1,087,123
-252,239
-19% -$4.27M
CUTR
85
DELISTED
Cutera, Inc.
CUTR
$19.6M 0.31%
487,347
+86,621
+22% +$3.99M
RHT
86
DELISTED
Red Hat Inc
RHT
$18.5M 0.29%
137,634
-121,026
-47% -$19.5M
GSKY
87
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$17.2M 0.27%
+812,328
New +$19.5M
SLDB icon
88
Solid Biosciences
SLDB
$780M
$16.7M 0.26%
+31,291
New +$9.63M
NITE
89
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$16.3M 0.25%
1,016,980
+7,007
+0.7% +$99.9K
BOLD
90
DELISTED
Audentes Therapeutics, Inc
BOLD
$16.3M 0.25%
+425,382
New +$15.8M
UBX
91
DELISTED
Unity Biotechnology
UBX
$11.5M 0.18%
+82,635
New +$12.1M
NTGN
92
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$10.8M 0.17%
+974,761
New +$13.3M
ANAB icon
93
AnaptysBio
ANAB
$1.53B
$9.83M 0.15%
138,338
+67,984
+97% +$5.7M
RCUS icon
94
Arcus Biosciences
RCUS
$3.38B
$9.4M 0.15%
768,279
-165,007
-18% -$2.59M
PAGS icon
95
PagSeguro Digital
PAGS
$2.71B
$9.36M 0.15%
337,283
+140,865
+72% +$4.66M
NCNA
96
NuCana
NCNA
$5.33M
$7.99M 0.13%
84
-5
-6% -$616K
CBLK
97
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$6.09M 0.1%
+234,327
New +$6.04M
IVTY
98
DELISTED
Invuity, Inc
IVTY
$5.3M 0.08%
1,360,334
– –
AUTL
99
Autolus Therapeutics
AUTL
$386M
$5.3M 0.08%
+197,874
New +$5.23M
CMTA
100
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$4.25M 0.07%
322,732
– –
1 2 3
4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2018 Portfolio in Review

As of Q2 2018, PFM Health Sciences held 130 positions worth $6.39B, up 30% from $4.92B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

PFM Health Sciences deployed $813M of net new capital in Q2 2018, opening 34 new positions and adding to 32 existing holdings. Its largest new stake was Clovis Oncology, Inc.: 2,337,225 shares worth $106M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 60% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Microsoft, an estimated $102M trimmed.

  • PFM Health Sciences's largest Q2 2018 buy was Clovis Oncology, Inc.: 2,337,225 shares worth $106M.
  • PFM Health Sciences added most to Esperion Therapeutics in Q2 2018, an estimated $67.2M increase.
  • PFM Health Sciences's biggest Q2 2018 reduction was Microsoft, cutting an estimated $102M.
  • PFM Health Sciences fully exited Bristol-Myers Squibb in Q2 2018, selling an estimated $198M.
  • PFM Health Sciences's ten largest holdings make up 30% of its $6.39B portfolio in Q2 2018.
  • PFM Health Sciences opened 34 new positions and closed 15 in Q2 2018.
  • PFM Health Sciences's portfolio value rose 30% quarter-over-quarter to $6.39B.

Based on PFM Health Sciences's 13F filing for Q2 2018, filed 14 Aug 2018.